定制化生长曲线:依据、验证与临床获益
本文综述胎儿生长与出生体重评估标准的依据,指出单一国际标准缺乏证据支持且可能有害,而考虑母亲身高、体重、产次和种族的定制化标准更贴合不良妊娠结局,英国推广后胎死率逐年下降。
要点
- 单一国际标准识别的小于胎龄儿缺乏营养不良证据支持
- 不同国家与种族间存在正常生理变异,一标准难适所有人群
- 定制化标准兼顾个体生理变异,英国推广后胎死率逐年下降
核心结论
- 定制化生长标准能更好反映胎儿大小两端的不良妊娠结局,并提高临床医生对生长评估的信心。
- 英国作为综合生长评估方案(GAP)的一部分推广后,胎儿生长受限高危儿的产前检出率稳步上升,英格兰胎死率逐年下降至历史最低水平。
- 2018年将推出涵盖100余种族类别分组的全球版定制化生长曲线,为胎儿生长提供个体化且普遍适用的标准。
研究设计与样本
- 本文为综述,对Intergrowth联盟提出的单一国际标准相关提案进行文献回顾与分析。
主要发现
- 单一国际标准将某些病例识别为小于胎龄儿,但缺乏证据表明这些病例由营养不良或发育迟缓所致。
- 不同国家与种族之间存在实质性正常生理变异,单一标准可能最终不适合任何人群,实施后可能有害。
- 国别特异性曲线可改善异常生长与不良结局的关联,但忽略了个体生理变异,而后者在任何异质人群中均存在并超过国家间差异。
- 定制化标准在胎儿大小两端均能更好反映不良妊娠结局,并在异常大小仅代表生理变异时提供安心。
关键数值与推荐
- 定制化标准需考虑母亲种族来源、身高、体重和产次,为每次妊娠设定生长与出生体重标准以评估实际生长。
- 全球版定制化生长曲线包含100余种族类别分组,于2018年推出。
临床怎么用
- 作者认为,应依据母亲种族来源、身高、体重和产次等特征进行定制化调整,为每次妊娠设定个体化生长与出生体重标准。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Appropriate standards for the assessment of fetal growth and birthweight are central to good clinical care, and have become even more important with increasing evidence that growth-related adverse outcomes are potentially avoidable. Standards need to be evidence based and validated against pregnancy outcome and able to demonstrate utility and effectiveness. A review of proposals by the Intergrowth consortium to adopt their single international standard finds little support for the claim that the cases that it identifies as small are due to malnutrition or stunting, and substantial evidence that there is normal physiologic variation between different countries and ethnic groups. It is possible that the one-size-fits-all standard ends up fitting no one and could be harmful if implemented. An alternative is the concept of country-specific charts that can improve the association between abnormal growth and adverse outcome. However, such standards ignore individual physiologic variation that affects fetal growth, which exists in any heterogeneous population and exceeds intercountry differences. It is therefore more logical to adjust for the characteristics of each mother, taking her ethnic origin and her height, weight, and parity into account, and to set a growth and birthweight standard for each pregnancy against which actual growth can be assessed. A customized standard better reflects adverse pregnancy outcome at both ends of the fetal size spectrum and has increased clinicians' confidence in growth assessment, while providing reassurance when abnormal size merely represents physiologic variation. Rollout in the United Kingdom has proceeded as part of the comprehensive Growth Assessment Protocol (GAP), and has resulted in a steady increase in antenatal detection of babies who are at risk because of fetal growth restriction. This in turn has been accompanied by a year-on-year drop in stillbirth rates to their lowest ever levels in England. A global version of customized growth charts with over 100 ethnic origin categories is being launched in 2018, and will provide an individualized, yet universally applicable, standard for fetal growth.
引用
- Gardosi J, Francis A, Turner S, et al. Customized growth charts: rationale, validation and clinical benefits. Am J Obstet Gynecol. 2018. PMID: 29422203. doi:10.1016/j.ajog.2017.12.011
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。